Bank of Montreal
EIGR

Bank of Montreal’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bank of Montreal’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,808
Closed -$463K – 5133
2021
Q1 		$463K Sell
1,808
-629
-26% -$198K ﹤0.01% 2686
2020
Q4 		$845K Buy
2,437
+128
+6% +$36.7K ﹤0.01% 2353
2020
Q3 		$581K Sell
2,309
-196
-8% -$61K ﹤0.01% 2268
2020
Q2 		$698K Buy
2,505
+164
+7% +$48.3K ﹤0.01% 2104
2020
Q1 		$379K Buy
2,341
+639
+38% +$204K ﹤0.01% 2099
2019
Q4 		$760K Buy
1,702
+1,610
+1,750% +$571K ﹤0.01% 2438
2019
Q3 		$28K Buy
92
+3
+3% +$974 ﹤0.01% 3902
2019
Q2 		$28K Buy
+89
New +$30.8K ﹤0.01% 3990
2018
Q3 		– Sell
-10
Closed -$4K – 4934
2018
Q2 		$4K Sell
10
-406
-98% -$145K ﹤0.01% 4200
2018
Q1 		$122K Buy
+416
New +$123K ﹤0.01% 2873
2017
Q1 		– Sell
-3
Closed -$1K – 4242
2016
Q4 		$1K Buy
+3
New +$1.1K ﹤0.01% 3989
2015
Q3 		– Sell
-3
Closed -$2K – 4206
2015
Q2 		$2K Sell
3
-4
-57% -$11.1K ﹤0.01% 3780
2015
Q1 		$57K Buy
+7
New +$61.2K ﹤0.01% 2869
2014
Q3 		– Hold
0
– -$3K – 4483
2014
Q2 		– Hold
0
– – – 4396

Other funds holding EIGR

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Montreal's EIGR Position: Q2 2021 in Review

Bank of Montreal sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2021, closing a stake of 1,808 shares — an estimated $463K sold.

Bank of Montreal first reported a position in EIGR in Q1 2015 and held it in 13 quarters. The position peaked at $845K in Q4 2020. 90 funds tracked by Wall St. Rank hold EIGR as of Q2 2021.

  • Bank of Montreal reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 1,808 Eiger BioPharmaceuticals, Inc. shares in Q2 2021, an estimated $463K.
  • Bank of Montreal first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2015 and held it in 13 quarters.
  • Bank of Montreal's Eiger BioPharmaceuticals, Inc. position peaked at $845K in Q4 2020.
  • 90 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.